Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan
Masayuki Iki, Kenji Fujimori, Shinichi Nakatoh, Junko Tamaki, Shigeyuki Ishii, Nobukazu Okimoto, Hironori Imano, Sumito Ogawa
Topics & Concepts
MedicineHip fractureInternal medicinePrednisoloneConfoundingGlucocorticoidRetrospective cohort studyCohort studyRheumatologyCohortCumulative doseSurgeryOsteoporosisBone health and osteoporosis researchBone and Joint DiseasesAdrenal Hormones and Disorders